GLP-1 Market
LLY $1157.08 ▼ -2.3% NVO $37.91 ▼ -1.0% PFE $28.52 ▼ -0.7% VKTX $32.60 ▲ +2.5% KLRA $11.42 ▲ +3.9% GPCR $31.27 ▼ -4.3% RHHBY $51.91 ▼ -0.7%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Relaxin

Company
Cambridge University Hospitals NHS Foundation Trust
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 1, 2026

Find a Clinical Trial Near Me

See recruiting studies for Relaxin and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT06526520

    Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer

    ART Fertility Clinics LLC 5 participants Est. completion 2026-12-31 1 site
    Other conditions: Frozen Embryo Transfer
    View official trial listing →
  • Recruiting NCT NCT07625553

    Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury

    Not yet reported River 2 Renal Corp. 430 participants Est. completion 2027-04-30 1 site
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT00004380

    Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis

    Not yet reported National Center for Research Resources (NCRR) 1 participants Est. completion 1997-12
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT00259103

    Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor

    Not yet reported Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies 72 participants Est. completion 2006-10 3 sites
    Other conditions: Labor, Induced
    View official trial listing →
  • Completed NCT NCT00259116

    A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure

    Not yet reported Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies 18 participants 1 site
    Heart failure
    View official trial listing →
  • Suspended NCT NCT00333307

    Evaluation of the Safety of Relaxin in Preeclampsia

    Not yet reported Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies 18 participants 2 sites
    Other conditions: Pre-Eclampsia
    View official trial listing →
  • Terminated NCT NCT00406575

    Recombinant Human Relaxin for the Treatment of Decompensated CHF

    Not yet reported Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies 11 participants Est. completion 2007-01 2 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT00520806

    Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure

    Not yet reported, Not yet reported Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies 1161 participants Est. completion 2012-09 3 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT00704665

    Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma

    Not yet reported University of Medicine and Dentistry of New Jersey 231 participants Est. completion 2001-12 Stand-alone
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT01166958

    Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?

    Not yet reported University of Wisconsin, Madison 26 participants Est. completion 2012-11 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01909492

    Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

    Providence Health & Services 30 participants Est. completion 2023-10-05 1 site
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT01979614

    Study of the Vascular Effects of Serelaxin

    Not yet reported Novartis Pharmaceuticals 58 participants Est. completion 2016-08-17 3 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02432456

    Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients

    Not yet reported Medical College of Wisconsin 153 participants Est. completion 2018-08 1 site
    Other conditions: Wounds and Injuries, Rib Fractures
    View official trial listing →
  • Completed NCT NCT02707094

    A Pilot Study Examining the Efficacy of Biomodulator Treatment for Chronic Low Back Pain

    Not yet reported Brooke Army Medical Center 75 participants Est. completion 2016-08-31 1 site
    Other conditions: Chronic Low Back Pain
    View official trial listing →
  • Active, not recruiting NCT NCT03449251

    A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 170 participants Est. completion 2026-12 1 site Stand-alone
    Cardiovascular diseaseType 2 diabetes
    View official trial listing →
  • Terminated NCT NCT03846024

    Orthosis of Acute Traumatic Rib Fractures Via RibFx Belt for Pain Alleviation and Improved Pulmonary Function

    Not yet reported University of Vermont Medical Center 27 participants Est. completion 2020-04-09 1 site
    Other conditions: Rib Fracture, Rib Fracture Multiple, Trauma, Trauma Chest, Trauma Injury, Trauma, Multiple
    View official trial listing →
  • Withdrawn NCT NCT04423614

    Preoperative Inspiratory Muscle Training

    Not yet reported University of Florida Est. completion 2022-01-05 Stand-alone
    Other conditions: Mechanical Ventilation Complication
    View official trial listing →
  • Completed NCT NCT04458454

    "Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"

    D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology 11 participants Est. completion 2020-02-20 1 site
    Other conditions: Infertility, Reproductive Techniques, Assisted, Oocyte Maturation
    View official trial listing →
  • Completed NCT NCT05076110

    Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

    Not yet reported Mayo Clinic 86 participants Est. completion 2025-10-25 1 site
    Other conditions: Hip Arthroscopy
    View official trial listing →
  • Completed NCT NCT05144828

    Efficacy of Intercostal CryoAnalgesia in Robotic Lung Resection

    Not yet reported Medical College of Wisconsin 33 participants Est. completion 2024-12-31 1 site
    Other conditions: Pain, Postoperative, Lung Diseases
    View official trial listing →
  • Completed NCT NCT05202496

    Effect of Systemic Administration of Vitamin D on the Rate of Orthodontic Tooth Movement - A Randomized Control Trial

    Not yet reported Postgraduate Institute of Dental Sciences Rohtak 24 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Angle Class I
    View official trial listing →
  • Terminated NCT NCT05204667

    Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. MioPain Study

    Not yet reported Aziende Chimiche Riunite Angelini Francesco S.p.A 172 participants Est. completion 2024-02-28 3 sites
    Other conditions: Low Back Pain
    View official trial listing →
  • Completed NCT NCT06264310

    To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF)

    Not yet reported River 2 Renal Corp. 33 participants Est. completion 2024-11-25 8 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT06299826

    A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure

    Not yet reported AstraZeneca 375 participants Est. completion 2026-02-10 57 sites
    Heart failure
    View official trial listing →
  • Enrolling by invitation NCT NCT06561035

    Reduce Opiate Exposure With ACL Surgery

    Not yet reported Campbell Clinic 56 participants Est. completion 2028-03 3 sites
    Other conditions: Anterior Cruciate Ligament Injuries
    View official trial listing →
  • Completed NCT NCT06628479

    Relaxin, Matrix Metalloproteinase-2 and Interleukin-6 in Women With Chronic Pelvic Pain

    Sanliurfa Mehmet Akif Inan Education and Research Hospital 60 participants Est. completion 2023-06-15 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Terminated NCT NCT06639087

    A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal Impairment

    Not yet reported AstraZeneca 8 participants Est. completion 2025-05-29 1 site
    Heart failure Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT06659965

    Intravenous Methocarbamol for Acute Pain After Spine Surgery

    The University of Texas Health Science Center, Houston 1270 participants Est. completion 2025-06-30 1 site
    Other conditions: Acute Post Operative Pain, Postsurgical Pain Management, Spine Surgery, Acute Pain, Postoperative, Multimodal Analgesia
    View official trial listing →
  • Status unknown NCT NCT06687486

    Effect of Autogenic Relaxation Therapy on Caregivers on Perceived Stress Quality of Life and Caregiver Burden

    Not yet reported Seda KARAKAYA ERGUN 64 participants Est. completion 2025-02-20 1 site Stand-alone
    Other conditions: Caregiver Burnout, Caregiver, Care Burden
    View official trial listing →
  • Completed NCT NCT06808165

    Relaxin and Placental Volume in Placenta Accreta Spectrum

    Başakşehir Çam & Sakura City Hospital 40 participants Est. completion 2023-01-01 1 site
    Other conditions: Placenta Accreta Spectrum, Placenta Accreta / Percreta
    View official trial listing →
  • Active, not recruiting NCT NCT06933602

    Progressive Relaxation for COPD: Effects on Insomnia and Satisfaction

    Not yet reported Ceylan Aksoy 70 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: COPD, Insomnia
    View official trial listing →
  • Not yet recruiting NCT NCT07359872

    Relaxin Therapy for Atrial Fibrillation

    Not yet reported, Not yet reported Deeptankar DeMazumder 208 participants Est. completion 2030-12-31 Stand-alone
    Cardiovascular diseaseHeart failure Other conditions: Atrial Fibrillation (AF), Arrhythmia, Oxidative Stress, Major Cardiovascular Event, Catheter Ablation, Ablation of Atrial Fibrillation
    View official trial listing →
  • Not yet recruiting NCT NCT07477340

    Plasma Relaxin Measurement Based on Endometrial Preparation for Embryo Transfer

    Hospices Civils de Lyon 60 participants Est. completion 2028-02-01 1 site
    Other conditions: Infertility, Embryos Transfert
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Relaxin, RLX

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.